Contract Pharma Manufacturing Solutions

  1. Scaling Organometallic Chemistry With Confidence 9/14/2026

    Scaling organometallic reactions requires robust cryogenic infrastructure and precise reagent preparation. Standardized facilities support seamless tech transfer, safe scale-up, and reliable supply.

  2. Quality Drive + People Powered 4/6/2026

    An integrated development and manufacturing approach that cuts handoffs, manages risk, and accelerates timelines by uniting formulation, analytics, production, and packaging.

  3. PTM 0.2µm Filters: PTFE Membrane 6/22/2026

    Achieve reliable gas and solvent filtration with hydrophobic membranes that resist moisture, support high flow, and maintain sterility for improved control and consistent performance.

  4. DPPC FIlters: Positive Charged, Dual Layered PES Membrane 6/22/2026

    Enhance filtration with dual-layer, charge-based membranes that remove bacteria, endotoxins, and impurities, ensuring consistent sterility, efficiency, and high performance in regulated environments.

  5. PPD Filters: Pleated Polypropylene Depth Media 6/22/2026

    Increase process efficiency using high-capacity depth filtration to remove contaminants, protect downstream filters, and extend filter life for more consistent results.

  6. API Sterilization 3/13/2026

    Leverage advanced aseptic processing and Quality Risk Management–driven controls that help ensure sterile-grade APIs when terminal sterilization is not a viable option.

  7. Keep A Close Eye On Quality With Excipients For Drug Formulation 8/27/2025

    Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.

  8. PNC Filters: Positively Charged Nylon 6,6 Membrane 6/22/2026

    Use charge-based membranes to remove bacteria, endotoxins, and contaminants, ensuring reliable sterility, stronger process control, and consistent results.

  9. Accelerated Antibody Production 12/20/2021

    Wherever your company is in its evolution, AGC Biologics can deliver at least 500 grams of monoclonal antibody manufactured under cGMP.

  10. Leveraging An Innovative Conjugation Technology For Better ADCs

    Learn how an advanced conjugation technology can provide a more uniform DAR profile, enhanced linker stability, and improved pharmacokinetic properties, paving the way for more efficacious ADCs.